Megan S Lim, MD, PhD

faculty photo
Professor of Pathology and Laboratory Medicine at the Hospital of the University of Pennsylvania
Department: Pathology and Laboratory Medicine
Graduate Group Affiliations

Contact information
Department of Pathology and Laboratory Medicine
Stellar Chance Office Suite 609C
422 Curie Blvd.
Philadelphia, PA 19104
Office: 215-898-4719
Fax: 215-898-9969
Education:
BS (Cell and Microbiology)
University of Calgary, 1983.
MS (Biochemistry, Cell Regulation Group, Department of Medical Biochemistry, Faculty of Medicine)
University of Calgary, 1985.
MD (Medicine)
University of Calgary, 1988.
PhD (Molecular Oncology)
University of Calgary joint with National Cancer Institute, National Institute of Health, 1999.
Permanent link
 
> Perelman School of Medicine   > Faculty   > Details

Selected Publications

Wierda WG, Byrd JC, Abramson JS, Bilgrami SF, Bociek G, Brander D, Brown J, Chanan-Khan AA, Chavez JC, Coutre SE, Davis RS, Fletcher CD, Hill B, Kahl BS, Kamdar M, Kaplan LD, Khan N, Kipps TJ, Lim MS, Ma S, Malek S, Mato A, Mosse C, Shadman M, Siddiqi T, Stephens D, Sundaram S, Wagner N, Dwyer M, Sundar H. : Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 4.2020, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. Harold J. Burstein (eds.). Harborside Press, 18(2): 185-217, February 2020.

Levantaki V, Bhattacharyya S, Lim MS.: Pathology and genetics of anaplastic large cell lymphoma. Semin in Diag Pathol. Justin A. Bishop, MD (eds.). Elsevier, 37: 57-71, January 2020 Notes: Epub 2019 Dec 18.

Rajan SS, Amin AD, Li L, Rolland DCM, Li H, Kwon D, Kweh MF, Arumoy A, Yan A, Basrur V, Elenitoba-Johnson KSJ, Chen X, Puvvada SD, Lussier YA, Bilbao D, Lim MS, Schatz JH: The mechanism of cancer drug addiction in ALK-Positive T-cell lymphoma. Oncogene. Dr. George Miller (eds.). Nature Publishing Group, Page: Epub ahead of print, December 2019.

Murga-Zamalloa C, Rolland DSC, Polk A, Wolfe A, Dewar H, Chowdury P, Önder Ö, Dewar R, Brown N, Bailey N, Inamdar K, Lim MS, Elenitoba-Johnson KSJ, and Ryan Wilcox: Colony-stimulating Factor 1 Receptor (CSF1R) Activates AKT/mTOR Signaling and Promotes T-cell Lymphoma Viability. Clinical Cancer Research. Keith T. Flaherty (eds.). American Association for Cancer Research, Page: 1486, October 2019 Notes: Epub ahead of print.

Shereck E. Day NS, Awasthi A, Ayello J, Chu Y, McGuinn C, van de Ven C, Lim MS, Cairo MS.: Immunophenotypic, cytotoxic, proteomic and genomic, characterization of human cord blood vs. peripheral blood CD56Dlm NK cells. Innate Immun. Otto Holst (Research Centre Borstel, Germany) (eds.). Sage publications, May 2019.

Lim MS, Beyer T, Babayan A, Bergmann M, Brehme M, Buyx A, Czernin J, Egger G, Elenitoba-Johnson KSJ, Gückel B, Jačan A, Haslacher H, Hicks RJ, Kenner L, Langanke M, Mitterhauser M, Pichler BJ, Salih HR, Schibli R, Schultz S, Simecek J, Simon J, Soares MO, Stelzl U, Wadsak W, Zatloukal K, Zeitlinger M, and Hacker M. : Advancing biomarker development through convergent engagement. Summary Report of the 2nd International Danube Symposium on biomarker development, molecular imaging and applied diagnostics. Molecular Imaging and Biology. Jorge R. Barrio (eds.). Springer Science and Business Media, May 2019.

Rollan DCM, Lim MS, Elenitoba-Johnson KSJ.: Mass spectrometry and proteomics in hematology. Seminars in Hematology. Adrian Wiestner, MD, PhD, Neal S. Young, MD (eds.). Elsevier, 56(1): 52-57, Jan 2019.

Lim MS: PMBCL: a molecular diagnosis? Blood. Bob Löwenberg (eds.). American Society of Hematology, 132(22): 2319-2320, Nov 2018.

Chu Y, Lee S, Shah T, Yin C, Barth M, Miles RR, Ayello J, Harrison L, Van de Ven C, Galandry P, Goldman SC, Lim MS, Hermiston M, McAllister-Luca LM, Giulino-Roth L, Perkins SL, Cairo MS.: Ibrutinib significantly inhibited Bruton's tyrosine kinase (BTK) phosphorylation, in-vitro proliferation and enhanced overall survival in a preclinical Burkitt lymphoma (BL) model. Oncoimmunology. Taylor & Francis, 8(1), Oct 2018.

Fajgenbaum DC, Oksendhendler E, Casper C, Uldrick, T, Kurzrock R, Yoshizaki K, Nasta S, Rossi JF, Wong R, Simpson D, Sato Y, Terriou L, Ferrero S, Zinzani PL, Hoffman C, Goodman A, Krymskaya V, Elenitoba-Johnson KSJ, Lim MS, Chadburn A, Penmaraju N, Leitch H, Jaffe ES, Jayanthan R, Chandrasakan S, Lechowicz MJ, Ruth J, Greenway A, Stone K, Shilling D, Mukherjee S, Partridge HL, Pierson SK, Streetly M, Schey S, Munshi N, Ide M, Srkalovic G, Fossa A, Dispenzieri A, Voorhees P, van Rhee F.: International, evidence-based consensus treatment guidelines for the management of idiopathic multicentric Castleman disease. Blood. Bob Löwenberg, MD, PhD (eds.). American Society of Hematology, Sep 2018.

back to top
Last updated: 06/22/2020
The Trustees of the University of Pennsylvania